Literature DB >> 11043811

Presence of human herpesvirus 6 and herpes simplex virus detected by polymerase chain reaction in surgical tissue from temporal lobe epileptic patients.

H Uesugi1, H Shimizu, T Maehara, N Arai, H Nakayama.   

Abstract

We investigated the presence of human herpesvirus 6 (HHV-6) and herpes simplex virus (HSV) in surgical tissue from temporal lobe epileptic patients. A total of 17 cases were studied, including eight males and nine females. The mean age was 24.9 +/- 11.1 years and the mean age of onset was 11.1 +/- 5.4 years. Five patients were diagnosed as encephalitis/meningitis and another three had a history of suspected encephalitis/meningitis, but no patient showed any obvious neurological symptom or mental handicap. Mesial and lateral temporal tissues were examined by polymerase chain reaction. Among six patients positive for HHV-6 (35%), the mesial temporal lobe was positive in four and the lateral temporal lobe was positive in three. Herpes simplex virus was positive in only one patient. Three of the six patients positive for HHV-6 did not show any apparent causes. Mild encephalitis/meningitis induced by HHV-6, a condition sometimes not recognized as encephalitis/meningitis, may be one of the most frequent causes of temporal lobe epilepsy.

Entities:  

Mesh:

Year:  2000        PMID: 11043811     DOI: 10.1046/j.1440-1819.2000.00758.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  13 in total

1.  Evidence that intractable temporal lobe epilepsy is influenced by genetic and environmentally acquired factors.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2004 Jul-Aug       Impact factor: 7.500

2.  Evaluation of RT-PCR and immunohistochemistry as tools for detection of enterovirus in the human pancreas and islets of Langerhans.

Authors:  Oskar Skog; Sofie Ingvast; Olle Korsgren
Journal:  J Clin Virol       Date:  2014-07-30       Impact factor: 3.168

Review 3.  Review part 2: Human herpesvirus-6 in central nervous system diseases.

Authors:  Karen Yao; John R Crawford; Anthony L Komaroff; Dharam V Ablashi; Steven Jacobson
Journal:  J Med Virol       Date:  2010-10       Impact factor: 2.327

4.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

Review 5.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

6.  Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections.

Authors:  D Donati; N Akhyani; A Fogdell-Hahn; C Cermelli; R Cassiani-Ingoni; A Vortmeyer; J D Heiss; P Cogen; W D Gaillard; S Sato; W H Theodore; S Jacobson
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

7.  Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes.

Authors:  Tih-Shih Lee; Shrikant Mane; Tore Eid; Hongyu Zhao; Aiping Lin; Zhong Guan; Jung H Kim; Jeffrey Schweitzer; David King-Stevens; Peter Weber; Susan S Spencer; Dennis D Spencer; Nihal C de Lanerolle
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

Review 8.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

9.  Natural history of temporal lobe epilepsy: antecedents and progression.

Authors:  Garima Shukla; Asuri N Prasad
Journal:  Epilepsy Res Treat       Date:  2012-03-26

10.  Novel marmoset (Callithrix jacchus) model of human Herpesvirus 6A and 6B infections: immunologic, virologic and radiologic characterization.

Authors:  Emily Leibovitch; Jillian E Wohler; Sheila M Cummings Macri; Kelsey Motanic; Erin Harberts; María I Gaitán; Pietro Maggi; Mary Ellis; Susan Westmoreland; Afonso Silva; Daniel S Reich; Steven Jacobson
Journal:  PLoS Pathog       Date:  2013-01-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.